3B BlackBio Dx Limited has disclosed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that it will conduct an analyst/investor meeting.
The meeting is scheduled for Wednesday, September 16, 2026 at 11:00 hrs India Time. The meeting will be a virtual one-on-one interaction with Marcellus Investment Managers, Mumbai via an investor conference call.
The company specified that it will use the Investor Presentation of Q1-FY27 for this meeting, which was previously intimated to the stock exchange via Ref.No.P-66/2026-27/27 dated August 13, 2026.
The disclosure explicitly states that only information available in the public domain will be shared and discussed during the interaction, and no unpublished price sensitive information will be disclosed.
The document includes a note that the date and time of the meeting is subject to change due to exigencies on the part of either the investor or the company.
This information has been hosted on the company's website at www.Kilpest.com and has been formally communicated to BSE Limited for information, action, and records.